Biocompatibility of three different membrane oxygenators: Effects on complement, neutrophil and monocyte activation

Perfusion

Volumn 12, Issue 6, 1997, Pages 369-375

  De Vroege, R ^a   Rutten, P M M J ^a   Kalkman, C ^a   Out, T A ^a   Jansen, P G M ^a   Eijsman, L ^a   De Mol, B J M ^a   Wildevuur, C R H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3A; INTERLEUKIN 6; LACTOFERRIN;

ADULT; ARTICLE; ARTIFICIAL MEMBRANE; BIOCOMPATIBILITY; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; FEMALE; GRANULOCYTE; HOLLOW FIBER MEMBRANE; HUMAN; INFLAMMATION; LEUKOCYTE; LIVER REGENERATION; MALE; MONOCYTE; NEUTROPHIL; OXYGENATOR; PRIORITY JOURNAL;

EID: 0030733536     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/026765919701200605     Document Type: Article

References (16)

1. Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 1981; 304: 497-503.
2. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983; 86: 845-57.
3. Kirklin JK. Prospects for understanding and elemination the deleterious effects of cardiopulmonary bypass. Ann Thorac Surg 1991; 51: 529-31.
4. Gillinov AM, Bator JM, Zehr KJ et al. Neutrophil adhesion molecule expression during cardiopulmonary bypass with bubble and membrane oxygenators. Annu Thorac Surg 1993; 56: 847-53.
5. Borowiec J, Thelin S, Bagge L, Nilsson L, Venge P, Hansson HE. Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. A clinical study. J Thorac Cardiovasc Surg 1992; 104: 642-47.
6. Teoh KH, Bradley CA, Gauldie J, Burrows H. Steroid inhibition of cytokine-mediated vasodilatation after warm heart surgery. Circulation 1995; 92: 347-53.
7. Steinberg BM, Grossi EA, Schwartz DS et al. Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass. Ann Thorac Surg 1995; 60: 525-29.
8. Gu YJ, Boonstra PW, Akkerman C, Mungroop H, Tigchelaar I, van Oeveren W. Blood compatibility of two different types of membrane oxygenator during cardiopulmonary bypass in infants. Int J Art Organs 1994; 17: 543-48.
9. Tamiya T, Yamasaki M, Meeo Y, Yamashiro T, Ogoshi S, Fujimoto S. Complement activation in cardiopulmonary bypass, with special reference to anaphylatoxin production in membrane and bubble oxygenators. Ann Thorac Surg 1988; 46: 47-57.
10. Van de Graaf EA, Jansen HM, Bakker MM, Alberts C, Eeftinck Schattenkerk JKM, Out TA. ELISA of complement C3a in bronchoalveolar lavage fluid. J Immunol Methods 1992; 147: 241-50.
11. Van de Graaf EA, Out TA, Kobesen A, Jansen HM. Lactoferrin and secretory IgA in the bronchoalveolar lavage fluid from patients with stable asthma. Lung 1991; 169: 275-83.
12. Helle M, Boeije L, de Groot E, de Vos A, Aarden L. Sensitive ELISA for interleukin-6. J Immunol Meth 1991; 138: 47-56.
13. Cavarocchi NC, Pluth JR, Shaff HV et al. Complement activation during cardiopulmonary bypass. Comparison of bubble and membrane oxygenators. J Thorac Cardiovasc Surg 1986; 91: 252-58.
14. Videm V, Fosse E, Mollnes TE, Garred P, Svennevig JL. Complement activation with bubble and membrane oxygenators in aortocoronary bypass grafting. Ann Thorac Surg 1990; 50: 387-91.
15. Benedetti M, De Caterina R, Bionda A et al. Blood-artificial surface interactions during cardiopulmonary bypass. A comparative study of four oxygenators. ISAIO 1990; 8: 488-97.
16. Kirklin JK, Chenoweth DE, Naftel DC et al. Effects of protamine administration after cardiopulmonary bypass on complement, blood elements and the hemodynamic state. Ann Thorac Surg 1986; 41: 193-99.